The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.

We use cookies to improve your experience and serve personalized ads.

By clicking Accept, you consent to our use of advertising cookies. See our Privacy Policy for details.

StocksMediumUpdated•Originally published 17 March 2026•Updated 19 March 2026•

1 min read

DOE Approves Nuclear Safety Design Agreement for Oklo Subsidiary Atomic Alchemy

Key Facts

1The U.S. Department of Energy (DOE) approved the Nuclear Safety Design Agreement (NSDA) for Atomic Alchemy's Groves Isotopes Test Reactor in Texas.

3 months ago

Version History

5 additional sources confirmed this story

Version 13 months ago

What changed: Added details from Oklo's FY2025 progress report and market analysis suggesting a potential price bottom for the stock despite current financial losses.

Oklo Inc. (NYSE: OKLO) announced that its subsidiary, Atomic Alchemy, received U.S. Department of Energy (DOE) approval for the Nuclear Safety Design Agreement regarding the Groves Isotopes Test Reactor in Texas. This milestone, part of the DOE's Reactor Pilot Program (RPP), marks a significant step in advancing the company's nuclear testing infrastructure. In its latest FY2025 progress report, Oklo indicated it remains on track to meet long-term strategic goals and market expectations. Market analysis suggests that OKLO shares may have reached a price bottom, even as the company faces headwinds like a current lack of revenue and profitability. Analysts view the combination of regulatory progress and steady operational updates as positive indicators for the stock's long-term recovery and risk mitigation.